<VariationArchive VariationID="1879031" VariationName="NM_000419.5(ITGA2B):c.1599_1600del (p.Ser534fs)" VariationType="Deletion" Accession="VCV001879031" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2023-01-21" MostRecentSubmission="2023-01-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1935780" VariationID="1879031">
      <GeneList>
        <Gene Symbol="ITGA2B" FullName="integrin subunit alpha 2b" GeneID="3674" HGNC_ID="HGNC:6138" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q21.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44372181" stop="44389649" display_start="44372181" display_stop="44389649" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42449549" stop="42466872" display_start="42449549" display_stop="42466872" Strand="-" />
          </Location>
          <OMIM>607759</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000419.5(ITGA2B):c.1599_1600del (p.Ser534fs)</Name>
      <CanonicalSPDI>NC_000017.11:44380245:ATA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q21.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="44380246" stop="44380247" display_start="44380246" display_stop="44380247" variantLength="2" positionVCF="44380245" referenceAlleleVCF="CAT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="42457614" stop="42457615" display_start="42457614" display_stop="42457615" variantLength="2" positionVCF="42457613" referenceAlleleVCF="CAT" alternateAlleleVCF="C" />
      </Location>
      <OtherNameList>
        <Name>NM_000419.5:c.1599_1600del</Name>
      </OtherNameList>
      <ProteinChange>S534fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.42457615_42457616del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.42457615_42457616del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.44380247_44380248del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.44380247_44380248del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008331.1" sequenceAccession="NG_008331" sequenceVersion="1" change="g.14259_14260del">
            <Expression>NG_008331.1:g.14259_14260del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_136688.1" sequenceAccession="NG_136688" sequenceVersion="1" change="g.891_892del">
            <Expression>NG_136688.1:g.891_892del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000419.5" sequenceAccession="NM_000419" sequenceVersion="5" change="c.1599_1600del" MANESelect="true">
            <Expression>NM_000419.5:c.1599_1600del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000410.2" sequenceAccession="NP_000410" sequenceVersion="2" change="p.Ser534fs">
            <Expression>NP_000410.2:p.Ser534fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_479" sequenceAccession="LRG_479">
            <Expression>LRG_479:g.14259_14260del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_479t1" sequenceAccession="LRG_479t1">
            <Expression>LRG_479t1:c.1598_1599del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_479p1" sequenceAccession="LRG_479p1" change="p.Ser534Profs">
            <Expression>LRG_479p1:p.Ser534Profs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000419.5(ITGA2B):c.1599_1600del (p.Ser534fs) AND Glanzmann thrombasthenia" Accession="RCV002511532" Version="2">
        <ClassifiedConditionList TraitSetID="734">
          <ClassifiedCondition DB="MedGen" ID="C0040015">Glanzmann thrombasthenia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2022-08-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-08-05" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-01-21" MostRecentSubmission="2023-01-21">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/ce7639f4-a59e-43df-b54d-a340158cfaeb</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="734" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3893" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">BLEEDING DISORDER, PLATELET-TYPE, 2</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glanzmann's thrombasthenia</ElementValue>
                <XRef ID="Thrombasthenia+of+Glanzmann+and+Naegeli/7074" DB="Genetic Alliance" />
                <XRef ID="32942005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thrombasthenia of Glanzmann and Naegeli</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glanzmann thrombasthenia</ElementValue>
                <XRef ID="MONDO:0100326" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glanzmann thrombasthenia type A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Diacyclothrombopathia 2B 3A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">PLATELET GLYCOPROTEIN IIb-IIIa DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thrombasthenia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BDPLT2</ElementValue>
                <XRef Type="MIM" ID="273800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2478" />
                <XRef ID="2478" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="849" DB="Orphanet" />
              <XRef ID="C0040015" DB="MedGen" />
              <XRef ID="MONDO:0100326" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS273800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="5507931" SubmissionDate="2023-01-13" DateLastUpdated="2023-01-21" DateCreated="2023-01-21">
        <ClinVarSubmissionID localKey="ce7639f4-a59e-43df-b54d-a340158cfaeb" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002820924" DateUpdated="2023-01-21" DateCreated="2023-01-21" Type="SCV" Version="1" SubmitterName="ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen" OrgID="507662" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-08-05">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/ce7639f4-a59e-43df-b54d-a340158cfaeb</URL>
          </Citation>
          <Comment>The NM_000419.5:c.1599_1600del (p.Ser534ProfsTer) variant in ITGA2B exon 16 is a frameshift variant predicted to cause a premature stop codon in biologically-relevant-exon 17/30 and is predicted to lead to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1). Although in silico tools predict the gain of a splice donor site 3 bp downstream that could lead to reading frame restoration, RT-PCR analysis of this region using RNA from a patient homozygous for the variant (GT-10, PMID: 25539746) confirmed the presence of mRNA with the 2 bp deletion and did not identify evidence of a restored reading frame (personal communication with Dr. Jose_x0019_ Rivera (Servicio de Hematolog_x0019_ıa y Oncolog_x0019_ıa Me_x0019_dica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonacio_x0019_n, Universidad de Murcia)). This variant has been detected in homozygosity in at least one proband with Glanzmann thrombasthenia (GT-10, PMID: 25539746). Total points: 0.5 (PM3_Supporting). This patient (Patient GT-10 in PMID: 25539746) displayed mucocutaneous bleeding and impaired aggregation with all agonists except ristocetin, which is highly specific for Glanzmann thrombasthenia (PP4_moderate). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). In summary, this variant meets the criteria to be classified as pathogenic for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PVS1, PP4_Moderate, PM2_Supporting, PM3_Supporting. (VCEP specifications version 2; date of approval 08/04/2022)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen Platelet ACMG Specifications v2-1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/mac6zhy2/clingen_platelet_acmg_specifications_v2-1.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ITGA2B" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_000419.5:c.1599_1600del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.11:g.44380247_44380248del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0100326" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12534641</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5507931" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0100326" MappingRef="MONDO">
        <MedGen CUI="C0040015" Name="Glanzmann thrombasthenia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

